Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × OTHER × Vincristine × Clear all

Phase

Status

Completed 203 Recruiting 55 Unknown 50 Terminated 43 Active not recruiting 34 Withdrawn 11 Not yet recruiting 11 Suspended 2 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, T-Cell, Peripheral 1

Interventions

Specimen Handling 7 Educational Status 7 Interviews as Topic 6 Chemoradiotherapy 5 Surveys and Questionnaires 4 Standard of Care 4 Radiotherapy 4 Fluorouracil 4 Fluorodeoxyglucose F18 4 Blood Specimen Collection 4 camrelizumab 3 Surgical Procedures, Operative 3 S 1 (combination) 3 Nivolumab 3 Methods 3 Early Intervention, Educational 3 Drug Therapy 3 Cisplatin 3 Carboplatin 3 Capecitabine 3 Biopsy 3 venetoclax 2 lenvatinib 2 fludarabine 2 Weights and Measures 2 Transcutaneous Electric Nerve Stimulation 2 Practice Guidelines as Topic 2 Patient Navigation 2 Paclitaxel 2 Oxaliplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07258680 2025-12-02

BrEto-TCL

N.N. Petrov National Medical Research Center of Oncology

Phase 3 Enrolling by invitation

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡